148 related articles for article (PubMed ID: 32843691)
1. Human transcription factor and protein kinase gene fusions in human cancer.
Salokas K; Weldatsadik RG; Varjosalo M
Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691
[TBL] [Abstract][Full Text] [Related]
2. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
[TBL] [Abstract][Full Text] [Related]
3. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas.
Yin X; Wang B; Gan W; Zhuang W; Xiang Z; Han X; Li D
J Exp Clin Cancer Res; 2019 Mar; 38(1):119. PubMed ID: 30849994
[TBL] [Abstract][Full Text] [Related]
4. Kinase impact assessment in the landscape of fusion genes that retain kinase domains: a pan-cancer study.
Kim P; Jia P; Zhao Z
Brief Bioinform; 2018 May; 19(3):450-460. PubMed ID: 28013235
[TBL] [Abstract][Full Text] [Related]
5. Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies.
Salokas K; Dashi G; Varjosalo M
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509339
[TBL] [Abstract][Full Text] [Related]
6. ChiPPI: a novel method for mapping chimeric protein-protein interactions uncovers selection principles of protein fusion events in cancer.
Frenkel-Morgenstern M; Gorohovski A; Tagore S; Sekar V; Vazquez M; Valencia A
Nucleic Acids Res; 2017 Jul; 45(12):7094-7105. PubMed ID: 28549153
[TBL] [Abstract][Full Text] [Related]
7. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
8. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
9. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
10. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
11. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
12. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
[TBL] [Abstract][Full Text] [Related]
13. Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
Lu H; Villafane N; Dogruluk T; Grzeskowiak CL; Kong K; Tsang YH; Zagorodna O; Pantazi A; Yang L; Neill NJ; Kim YW; Creighton CJ; Verhaak RG; Mills GB; Park PJ; Kucherlapati R; Scott KL
Cancer Res; 2017 Jul; 77(13):3502-3512. PubMed ID: 28512244
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Human-Similar Gene Fusions in Canine Cancers.
Ulvé R; Rault M; Bahin M; Lagoutte L; Abadie J; De Brito C; Coindre JM; Botherel N; Rousseau A; Wucher V; Cadieu E; Thieblemont C; Hitte C; Cornevin L; Cabillic F; Bachelot L; Gilot D; Hennuy B; Guillaudeux T; Le Goff A; Derrien T; Hédan B; André C
Cancer Res; 2017 Nov; 77(21):5721-5727. PubMed ID: 28883003
[TBL] [Abstract][Full Text] [Related]
15. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
16. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
[TBL] [Abstract][Full Text] [Related]
17. Genetic fusions favor tumorigenesis through degron loss in oncogenes.
Liu J; Tokheim C; Lee JD; Gan W; North BJ; Liu XS; Pandolfi PP; Wei W
Nat Commun; 2021 Nov; 12(1):6704. PubMed ID: 34795215
[TBL] [Abstract][Full Text] [Related]
18. The molecular signature of oncofusion proteins in acute myeloid leukemia.
Martens JH; Stunnenberg HG
FEBS Lett; 2010 Jun; 584(12):2662-9. PubMed ID: 20388510
[TBL] [Abstract][Full Text] [Related]
19. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
Wong D; Yip S; Sorensen PH
Pathol Oncol Res; 2020 Jul; 26(3):1385-1399. PubMed ID: 31256325
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy for fusion-driven high-risk acute leukemia.
Pikman Y; Stegmaier K
Blood; 2018 Sep; 132(12):1241-1247. PubMed ID: 30049809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
